SEC 13F Intelligence

Managers / Q1 2024 · view latest →

TradeLink Capital LLC

CIK 0001642044 · 71 S. WACKER DR., SUITE 1900, CHICAGO, IL, 60606 · 312-264-2196

Reported Value
$7M
Q1 2024
Positions
21
Filings on Record
32
2019–present window
Filed
May 13, 2024
original filing

Summary

Tradelink Capital LLC reported $7M in U.S.-listed holdings across 21 positions for Q1 2024.

The portfolio is heavily concentrated: CRH alone accounts for 44.8% of reported value.

Compared with Q4 2023, the fund opened 21 new positions and exited 13.

Portfolio Metrics

Turnover
+97.2%
vs prior filed quarter
Top-10 Concentration
+85.8%
share of reported value
Largest Position
+44.8%
Crh
New / Exited
21 / 13
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $3MQ4 ’18Q1 ’19: $19MQ2 ’19: $7MQ3 ’19: $14MQ4 ’19: $3MQ4 ’19Q1 ’20: $3MQ2 ’20: $24MQ3 ’20: $5MQ4 ’20: $314,000Q4 ’20Q1 ’21: $7MQ2 ’21: $4MQ3 ’21: $12MQ4 ’21: $527,000Q4 ’21Q1 ’22: $22MQ2 ’22: $4MQ3 ’22: $5MQ4 ’22: $4,642Q4 ’22Q2 ’23: $3MQ3 ’23: $3,227Q4 ’23: $7MQ1 ’24: $7MQ1 ’24Q2 ’24: $35MQ1 ’25: $16MQ2 ’25: $28MQ3 ’25: $14MQ3 ’25Q4 ’25: $13MQ1 ’26: $13Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 96.9%Other: 3.1%
  • Common Stock · 96.9% · $7M
  • Other · 3.1% · $206,000

Quarter-over-Quarter Changes full breakdown →

vs Q4 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
CRHCrh PlcNEW+35.0K35.0K+$3M$3M
SNXTD SYNNEX CorpNEW+6.0K6.0K+$679,000$679,000
SOLVSolventum CorpNEW+5.0K5.0K+$348,000$348,000
SXTSensient Technologies CorpNEW+5.0K5.0K+$343,000$343,000
AUBAtlantic Union Bankshares CorpNEW+9.0K9.0K+$318,000$318,000
HZOMarineMax IncNEW+6.9K6.9K+$230,000$230,000
BURBurford Capital LtdNEW+13.9K13.9K+$222,000$222,000
SLGNSilgan Holdings IncNEW+4.3K4.3K+$209,000$209,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2024

21 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CRHCrh Plchistory →COM44.83%$3M35.0K
2SNXTD SYNNEX Corphistory →COM10.08%$679,0006.0K
3SOLVSolventum Corphistory →COM5.17%$348,0005.0K
4SXTSensient Technologies Corphistory →COM5.09%$343,0005.0K
5AUBAtlantic Union Bankshares Corphistory →COM4.72%$318,0009.0K
6HZOMarineMax Inchistory →COM3.41%$230,0006.9K
7BURBurford Capital Ltdhistory →COM3.30%$222,00013.9K
8SLGNSilgan Holdings Inchistory →COM3.10%$209,0004.3K
9HZO 04/19/2024 PUT 30COM3.06%$206,0006.2K
10AXTAAxalta Coating Systems Ltdhistory →COM3.06%$206,0006.0K
11XRXXerox Holdings Corphistory →COM3.06%$206,00011.5K
12ABMABM Industries Inchistory →COM3.03%$204,0004.6K
13Petiq IncCOM2.88%$194,00010.6K
14GDOTGreen Dot Corphistory →COM1.54%$104,00011.2K
15BLNDBlend Labs IncCOM0.77%$52,00016.0K
16LABStandard BioTools IncCOM0.70%$47,00017.3K
17TSHATaysha Gene Therapies IncCOM0.48%$32,00011.3K
18Perspective Therapeutics IncCOM0.48%$32,00027.0K
19Qurate Retail Inc Series ACOM0.46%$31,00025.3K
20URGUr-Energy IncCOM0.43%$29,00018.3K
21AKBAAkebia Therapeutics IncCOM0.36%$24,00013.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$13M34May 13, 202613F-HRchanges · EDGAR ↗
Q4 2025$13M27Feb 4, 202613F-HRchanges · EDGAR ↗
Q3 2025$14M31Nov 3, 202513F-HRchanges · EDGAR ↗
Q2 2025$28M51Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$16M40May 8, 202513F-HRchanges · EDGAR ↗
Q4 2024Under review26Feb 7, 202513F-HRchanges · EDGAR ↗
Q3 2024Under review1Nov 12, 202413F-HRchanges · EDGAR ↗
Q2 2024$35M88Aug 8, 202413F-HRchanges · EDGAR ↗
Q1 2024$7M21May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$7M19Feb 13, 202413F-HRchanges · EDGAR ↗
Q3 2023$3,2272Nov 9, 202313F-HRchanges · EDGAR ↗
Q2 2023$3M10Aug 11, 202313F-HRchanges · EDGAR ↗
Q4 2022$4,6422Feb 13, 2023RESTATEMENTchanges · EDGAR ↗
Q3 2022$5M4Nov 8, 202213F-HRchanges · EDGAR ↗
Q2 2022$4M1Aug 9, 202213F-HRchanges · EDGAR ↗
Q1 2022REVEALED$22M32May 10, 202213F-HRchanges · EDGAR ↗
Q4 2021$527,0002Jan 27, 202213F-HRchanges · EDGAR ↗
Q3 2021$12M4Oct 29, 202113F-HRchanges · EDGAR ↗
Q2 2021$4M1Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$7M15May 7, 202113F-HRchanges · EDGAR ↗
Q4 2020$314,0002Feb 1, 202113F-HRchanges · EDGAR ↗
Q3 2020$5M5Nov 2, 202013F-HRchanges · EDGAR ↗
Q2 2020$24M53Jul 29, 202013F-HRchanges · EDGAR ↗
Q1 2020$3M2May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$3M6Feb 10, 202013F-HRchanges · EDGAR ↗
Q3 2019$14M24Oct 28, 201913F-HRchanges · EDGAR ↗
Q2 2019$7M10Jul 31, 201913F-HRchanges · EDGAR ↗
Q1 2019$19M33Apr 25, 201913F-HRchanges · EDGAR ↗
Q4 2018$3M2Feb 8, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.